Angiotensin receptor blocker add-on therapy in portal hypertension: to use angiotensin receptor blocker or not to use, that is the question
- PMID: 25548739
- PMCID: PMC4278064
- DOI: 10.3350/cmh.2014.20.4.345
Angiotensin receptor blocker add-on therapy in portal hypertension: to use angiotensin receptor blocker or not to use, that is the question
Conflict of interest statement
The authors have no conflicts of interests to disclose.
Comment on
-
Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B.Clin Mol Hepatol. 2014 Dec;20(4):347-54. doi: 10.3350/cmh.2014.20.4.347. Epub 2014 Dec 24. Clin Mol Hepatol. 2014. PMID: 25548740 Free PMC article.
References
-
- Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99:1401–1407. - PubMed
-
- Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254–2261. - PubMed
-
- Huang HC, Chang CC, Wang SS, Lee FY, Teng TH, Lee JY, et al. The roles of angiotensin II receptors in the portosystemic collaterals of portal hypertensive and cirrhotic rats. J Vasc Res. 2012;49:160–168. - PubMed
-
- Bataller R, Ginès P, Nicolás JM, Görbig MN, Garcia-Ramallo E, Gasull X, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology. 2000;118:1149–1156. - PubMed
-
- González-Abraldes J, Albillos A, Bañares R, Del Arbol LR, Moitinho E, Rodríguez C, et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology. 2001;121:382–388. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
